Device Week, 23 October 2020 – Conference Spotlight – TCT, HLTH

In this week’s podcast, Medtech Insight's managing editor Marion Webb has an update from the virtual HLTH panel discussions on telehealth and robotics. Deputy editor Reed Miller discusses trial results from Boston Scientific’s next-generation Accurate neo2 self-expanding aortic valve presented during the Transcatheter Cardiovascular Therapeutics (TCT) meeting. For more information on Medtech Insight and to start a free trial, click here: http://bit.ly/2w7LnlR Medtech Insight articles addressing topics discussed in this episode: HLTH 2020: Panel Finds Pandemic Accelerates Uses For Robots In Health Care, Even ‘Zumba’ HLTH 2020: Amwell CEO Foresees Patient Demand Will Drive Telehealth’s Future Boston Scientific’s TAVR Pipeline Delayed; FDA Approval Of Accurate neo2 Set For 2024